MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT05463796 | RECRUITING
5000 participants

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-17
Start Date:
2023-04-25
Completion:
2030-03-25
Conditions
  • Cancer Risk
  • Cancer Predisposition Syndrome
  • Hereditary Cancer Prediction
  • Childhood Cancer Survivors
  • Adult Cancer Survivors
  • IARC Carcinogens
  • Smoking History
  • Lung Cancer
  • Ductal/Lobular Carcinoma
  • Barrett Esophagus
  • Pancreatic Precursor Lesions
  • Colonic Dysplasia/Adenomata
  • Non-Alcoholic Fatty Liver Disease
  • Non Alcoholic Steatohepatitis
  • Cirrhosis
  • High Grade Prostatic Epithelial Neoplasia
  • High-grade Bladder Urothelial Dysplasia/Carcinoma in Situ
  • Adenomatous Hyperplasia
  • High-risk Oral Precancerous Diseases
  • Melanocytic Lesion, Adult
  • Hematologic Malignancy
  • Lung; Node
  • Serous Tubal Intraepithelial Carcinoma
  • Endometrial Intraepithelial Neoplasia
  • Cervical and Endocervical Carcinoma in Situ
  • Vulvar Intraepithelial Neoplasia
  • Nephrogenic Rests
  • Benign Bone Lesions With Risk of Malignant Degeneration
  • Giant Cell Tumor
  • Osteochondroma
  • Spitz Nevus
Interventions
  • OTHER
No Results Yet
NCT05455190 | COMPLETED | NA
209 participants

Parks & Pediatrics Fit Together

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-12-15
Completion:
2026-07-06
Conditions
  • Pediatric Obesity
  • Implementation
Interventions
  • BEHAVIORAL
No Results Yet
NCT05415709 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1
35 participants

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-06-13
Completion:
2026-12-31
Conditions
  • Fallopian Tube Endometrioid Adenocarcinoma
  • Fallopian Tube Mucinous Adenocarcinoma
  • Fallopian Tube Serous Adenocarcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Mucinous Adenocarcinoma
  • Ovarian Serous Adenocarcinoma
  • Primary Peritoneal Endometrioid Adenocarcinoma
  • Primary Peritoneal Serous Adenocarcinoma
  • Stage III Fallopian Tube Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Primary Peritoneal Cancer AJCC v8
  • Stage IIIA Fallopian Tube Cancer AJCC v8
  • Stage IIIA Ovarian Cancer AJCC v8
  • Stage IIIA Primary Peritoneal Cancer AJCC v8
  • Stage IIIA1 Fallopian Tube Cancer AJCC v8
  • Stage IIIA1 Ovarian Cancer AJCC v8
  • Stage IIIA2 Fallopian Tube Cancer AJCC v8
  • Stage IIIA2 Ovarian Cancer AJCC v8
  • Stage IIIB Fallopian Tube Cancer AJCC v8
  • Stage IIIB Ovarian Cancer AJCC v8
  • Stage IIIB Primary Peritoneal Cancer AJCC v8
  • Stage IIIC Fallopian Tube Cancer AJCC v8
  • Stage IIIC Ovarian Cancer AJCC v8
  • Stage IIIC Primary Peritoneal Cancer AJCC v8
  • Stage IV Fallopian Tube Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Primary Peritoneal Cancer AJCC v8
  • Stage IVA Fallopian Tube Cancer AJCC v8
  • Stage IVA Ovarian Cancer AJCC v8
  • Stage IVA Primary Peritoneal Cancer AJCC v8
  • Stage IVB Fallopian Tube Cancer AJCC v8
  • Stage IVB Ovarian Cancer AJCC v8
  • Stage IVB Primary Peritoneal Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
No Results Yet
NCT05408845 | RECRUITING | PHASE2
146 participants

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2023-03-03
Completion:
2028-07-31
Conditions
  • Metastatic Salivary Gland Carcinoma
  • Recurrent Salivary Gland Carcinoma
  • Stage III Major Salivary Gland Cancer AJCC v8
  • Stage IV Major Salivary Gland Cancer AJCC v8
  • Unresectable Salivary Gland Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT05401227 | RECRUITING | PHASE1
120 participants

Glutamatergic Mechanisms: Aim2

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-10-15
Completion:
2028-08-31
Conditions
  • Healthy
Interventions
  • DRUG
No Results Yet
NCT05327686 | RECRUITING | PHASE2
240 participants

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2023-02-01
Completion:
2028-06-15
Conditions
  • Metastatic Renal Cell Carcinoma
  • Stage III Renal Cell Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
  • Unresectable Renal Cell Carcinoma
Interventions
  • BIOLOGICAL
  • DRUG
  • PROCEDURE
  • RADIATION
No Results Yet
NCT05312736 | ACTIVE_NOT_RECRUITING
46 participants

Gyrate Atrophy Ocular and Systemic Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-17
Start Date:
2023-11-21
Completion:
2028-12-31
Conditions
  • Gyrate Atrophy
  • Gyrata of Choroid and Retina; Atrophy
  • Ornithine-δ-aminotransferase
  • OAT
  • Chorioretinal Degeneration
No Results Yet
NCT05305287 | RECRUITING | PHASE4
60 participants

Quantifying Hepatic Mitochondrial Fluxes in Humans

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-11-01
Completion:
2027-03-31
Conditions
  • Non-Alcoholic Fatty Liver Disease
  • Type 2 Diabetes
  • Mitochondrial Metabolism Disorders
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT05201833 | ACTIVE_NOT_RECRUITING
300 participants

TRACK-TBI Longitudinal Biomarker Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-17
Start Date:
2022-03-01
Completion:
2026-12-30
Conditions
  • Traumatic Brain Injury
Interventions
  • BEHAVIORAL
  • PROCEDURE
No Results Yet
NCT05079841 | ACTIVE_NOT_RECRUITING | PHASE4
933 participants

The Stimulation To Induce Mothers Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2021-11-15
Completion:
2028-11-30
Conditions
  • Oxytocin
  • Labor Pain
  • Induction of Labor Affected Fetus / Newborn
  • Physiologic Effects of Drugs
Interventions
  • DEVICE
  • DRUG
No Results Yet
NCT05053152 | ACTIVE_NOT_RECRUITING | PHASE2
194 participants

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-04-20
Completion:
2029-02-01
Conditions
  • Oligometastatic Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Prostate Ductal Adenocarcinoma
  • Prostate Intraductal Carcinoma
  • Stage IVB Prostate Cancer AJCC v8
Interventions
  • PROCEDURE
  • OTHER
  • DRUG
  • RADIATION
No Results Yet
NCT05047185 | TERMINATED | PHASE2
34 participants

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-04-19
Completion:
2025-06-30
Conditions
  • Hereditary Angioedema
  • Hereditary Angioedema Type I
  • Hereditary Angioedema Type II
  • Hereditary Angioedema Types I and II
  • Hereditary Angioedema Attack
  • Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
  • Hereditary Angioedema - Type 1
  • Hereditary Angioedema - Type 2
  • C1 Esterase Inhibitor Deficiency
  • C1 Inhibitor Deficiency
Interventions
  • DRUG
Results Available
Previous
Sorted by latest updates
Next
Showing 40 trials per page